New tetanus protection shot for high-risk adults
Part of Infections clinical trials.
This trial tests a new injection (SNA02-48) designed to protect adults who are at high risk of tetanus infection. Tetanus is a serious bacterial infection that can cause severe muscle stiffness and life-threatening complications; this study evaluates whether this new protective treatment is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have had a recent exposure to tetanus (for example, through a dirty wound or injury)
- You have NOT had tetanus infection before, or currently suspected tetanus
- You have not received the standard tetanus vaccine more than 3 times, or if you have, your last dose was more than 6 months ago
- You are willing to use reliable birth control for 6 months after receiving the injection (if you can get pregnant or father children)
- You do not have severe allergies to vaccines or monoclonal antibodies (proteins used in some treatments)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called GR2001 to help prevent tetanus after a dirty wound. It is for people who have not had many tetanus shots before and need extra protection.
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
This study compares a new tetanus shot (siltartoxatug) with standard tetanus treatments to see if it works as well. It is for people aged 18 and older who need tetanus protection after an injury.
This study looks at how well a tetanus booster vaccine works by testing your saliva and blood. It includes healthy children, young adults, pregnant women, and adults with certain medical conditions.
This study tests a new type of patch with tiny needles (microneedles) that delivers a tetanus vaccine booster through your skin instead of a traditional injection. Researchers want to confirm it's safe and works well in healthy adults.
This trial tests a new combination vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and helps the body build immunity.
Hear when a new Tetanus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.